Feverfew for Migraine Prevention, Daily Protocol

Category: Pain Relief

Feverfew for migraine prevention: how parthenolide blocks vasogenic migraine triggers, Cochrane review evidence and daily protocol.

Traditional uses & benefits

• Reducing how often migraines occur and how severe they are
• Prevention only, not for stopping an active migraine

Ingredients

• Standardised feverfew extract (0.2% parthenolide) (50–100 mg per day)

How to prepare

1. Take 50–100 mg standardised feverfew extract (0.2% parthenolide) daily with food. 2. Use consistently every day — this is a preventive protocol, not on-demand. Missing doses reduces effectiveness. 3. Allow 1–3 months before evaluating effectiveness. Many people notice reduced attack frequency after 4–8 weeks. 4. Do not stop abruptly — taper the dose gradually over 2 weeks to avoid post-feverfew rebound headache and anxiety. 5. If taking blood thinners (warfarin, aspirin, DOACs), consult your doctor before starting — parthenolide has antiplatelet activity.

Why it works

Parthenolide blocks platelet serotonin release and thromboxane synthesis, two of the main triggers of migraine vasospasm, taken daily before attacks occur.

Time to effect

Full benefit at 3 months of consistent daily use

Not right for

Not for stopping a migraine once it has started. Not for pregnancy or blood thinner users. Must be taken daily, not on demand. Do not stop abruptly.

What the evidence says

In Murphy et al. (1988), daily raw feverfew leaf produced a 24% reduction in migraine attack frequency and significant improvement in headache-free days compared to placebo.

When to take it

preventive

Common mistakes

• Taking only during a migraine attack — feverfew is a preventive medicine, not an acute analgesic
• Stopping abruptly after months of use — sudden discontinuation can cause a "rebound" increase in migraine frequency
• Chewing raw feverfew leaves — causes mouth ulcers; use standardised capsule or tincture forms
• Using preparations without standardised parthenolide content (minimum 0.2%)

How we read the research

Cochrane review of 5 RCTs confirms significant migraine frequency reduction. Murphy 1988 landmark RCT: 24% reduction in attack frequency.

Sources

• Feverfew for migraine prevention — Cochrane review (Pittler 2004) (2004): Pittler MH & Ernst E. 5 RCTs. Feverfew significantly reduced migraine frequency vs placebo.
• Feverfew for migraine prevention (Murphy 1988) (1988): Murphy JJ et al. n=72. 24% reduction in attack frequency, reduced severity vs placebo.

Back to the PlantRx Remedy Library

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.